Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,450.8
-30.3 (-1.22%)

 

  • STI Straits Times Index
    2,450.8
    -30.3 (-1.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,500.8
    4.3 (0.29%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,311.1
    -431.4 (-1.82%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,223.2
    -56.5 (-1.72%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,087.8
    -258.7 (-1.11%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,842.8
    -75.2 (-1.53%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,147.9M
  • Value: 1,185.0M
  • Rise: 88
  • Fall: 215
  • Unch: 479

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.144-0.007
Clearbridge0.172+0.016
Jiutian Chemical0.046-
Singtel2.120-0.080
AsiaMedic0.024+0.002
CWX Global0.001-
Biolidics0.370+0.055
Genting Sing0.670-0.010
ComfortDelGro1.420-0.040
NetLink NBN Tr0.950-

World Indices

World Indices
Name Last Change
Nasdaq 10,633.0 -330.6
HSI 23,311.1 -431.4
HSCEI 9,371.2 -187.6
Jakarta 4,842.8 -75.2
Nikkei 225 23,087.8 -258.7
SSE Comp 3,223.2 -56.5
Shanghai A 3,378.0 -59.3
Shanghai B 246.6 -3.4
KOSPI 2,272.7 -60.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NEKTAR THERAPEUTICS NEKTAR THERAPEUTICS
Updated on 23 Sep 2020 (End of trading day)
Last (USD): 18.910 Change: -0.990 High: 20.100 Remarks: -
Change (%): -4.97 Low: 18.900
Open 19.840 Yesterday's Close 19.9
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,035,463 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.46320 Trailing EPS (USD) e -2.40147 NAV (USD) b 7.0220
PE a - Trailing PE f - Price / NAV b 2.6930
Dividend (USD) d - Cash In Hand (USD) g 0.2792 Issued & Paid-up Shares c 178,900,000
Dividend Yield (%) d - Price / Cash In Hand g 67.729 Treasury Shares h -
Market Cap (M) 3,382.999 Enterprise Value (M) 2,569.658
Piotroski F Score 1 Exchange Code NKTR Par Value ( $ ) n.a.
52 Weeks Volatility (%) 58.50 Free Float (%) 98.7
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NEKTAR THERAPEUTICS NASDAQ 3,382.999 - - 2.6930 -
Industry Pharmaceuticals: Major NASDAQ 1,687.785 114.250 45.797 2.6322 0.008
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 127,429.401 39.165 10.374 1.7923 2.309
Local Peer ROYALTY PHARMA PLC NASDAQ 25,364.889 10.800 10.800 6.1015 -
Local Peer CUREVAC NV NASDAQ 8,476.616 - - -176.9316 -
Local Peer REPLIGEN CORP NASDAQ 7,475.320 349.133 241.615 6.7956 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,647.291 - - 13.5837 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,248.156 6.071 6.901 0.7050 2.733
Local Peer ALLAKOS INC NASDAQ 3,840.215 - - 8.5910 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 3,814.973 - - 9.5138 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 3,651.199 - - 15.7632 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 3,524.055 - - 4.9577 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 3,319.190 - - 9.4446 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 2,953.770 - - 12.2633 -
Other Local Peers IGM BIOSCIENCES INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ANNEXON INC (NASDAQ), PETIQ INC (NASDAQ), PROVENTION BIO INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), TRICIDA INC (NASDAQ), 89BIO INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), IMARA INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), IMMUNIC INC (NASDAQ), DURECT CORP (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), OBSEVA SA (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), EVOLUS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), NOVAN INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 10 ORD SHS (R/S) (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PAINREFORM LTD (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), MANNATECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), SUN BIOPHARMA INC (NASDAQ), ENTERA BIO LTD (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 380,284.521 25.153 25.043 6.0384 2.596
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 215,744.397 30.610 29.889 4.0092 2.107
Global Peer MERCK & CO INC NYSE 208,991.101 21.232 19.944 7.5606 2.746
Global Peer PFIZER INC NYSE 200,047.680 12.294 14.118 3.1094 4.039
Global Peer ABBVIE INC NYSE 153,787.286 19.611 22.282 10.4561 4.222
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 146,084.123 108.975 67.860 11.9378 2.461
Global Peer ELI LILLY AND COMPANY NYSE 143,288.771 30.895 25.505 35.0089 1.724
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 132,959.331 38.662 - 2.7083 2.815
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 125,791.664 21.543 20.509 13.9000 1.639
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 94,803.017 15.998 14.828 5.6445 5.161
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), HYGEIA HEALTH (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), HENLIUS-B (HKEx), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), AKESO-B (HKEx), CMS (HKEx), HEPALINK (HKEx), ADC THERAPEUTICS SA (NYSE), TRAD CHI MED (HKEx), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), OCUMENSION-B (HKEx), INNOCARE-B (HKEx), SSY GROUP (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), Soho Global Health Tbk. (IDX), CSTONE PHARMA-B (HKEx), CKLIFE SCIENCES (HKEx), Kimia Farma Tbk. (IDX), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), HUA MEDICINE-B (HKEx), IGBB (Bursa), SHINEWAY PHARM (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), STARPHARMA HOLDINGS LIMITED (ASX), FUSEN PHARM (HKEx), AFT PHARMACEUTICALS LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), BSTEAD (Bursa), TOT BIOPHARM-B (HKEx), PHARMA (Bursa), LANNETT CO INC (NYSE), ZHONGZHIPHARM (HKEx), DAWNRAYS PHARMA (HKEx), CH BIOTECH SER (HKEx), RECCE PHARMACEUTICALS LTD (ASX), BIOMX INC (NYSE American), IX Biopharma (SGX), KOTRA (Bursa), Merck Tbk. (IDX), Hyphens Pharma (SGX), NEW RAY MEDIC (HKEx), IP (SET), NEP INTERLONG (HKEx), Phapros Tbk. (IDX), PAK FAH YEOW (HKEx), ONCOSIL MEDICAL LIMITED (ASX), RACE ONCOLOGY LTD (ASX), PALLA PHARMA LTD (ASX), NOVA (Bursa), NOXOPHARM LTD (ASX), CHARMACY PHAR (HKEx), BIOHLDG (Bursa), NC HEALTHCARE (HKEx), WAI YUEN TONG (HKEx), IMMURON LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), INVION LTD (ASX), PURAPHARM (HKEx), SANAI HEALTH GP (HKEx), EXTRAWELL PHAR (HKEx), JCT (SET), MEDLAB CLINICAL LIMITED (ASX), AGEX THERAPEUTICS INC (NYSE American), ANNOVIS BIO INC (NYSE American), EXOPHARM LTD (ASX), PHARMAXIS (ASX), ACRUX (ASX), SUNZEN (Bursa), FIJI KAVA LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), TALI DIGITAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), CRESO PHARMA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), CELLMID LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.430
-7.03 %
10 Days -+0.090
+0.48 %
20 Days --0.260
-1.36 %
Medium Term Return 3 Months --3.580
-15.92 %
6 Months -+1.400
+8.00 %
1 Year -+1.350
+7.69 %
Long Term Return 2 Years --42.000
-68.95 %
3 Years --4.770
-20.14 %
5 Years -+8.200
+76.56 %
Annualised Return Annualised --
+12.04 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 13.630 - 28.600 Change From 1 Year Low +5.280 % Change From 1 Year Low (%) +38.74
Change From 1 Year High -9.690 % Change From 1 Year High (%) -33.88
2 Years Range 13.630 - 61.470 Change From 2 Years Low +5.280 % Change From 2 Years Low (%) +38.74
Change From 2 Years High -42.560 % Change From 2 Years High (%) -69.24
5 Years Range 9.920 - 111.360 Change From 5 Years Low +8.990 % Change From 5 Years Low (%) +90.62
Change From 5 Years High -92.450 % Change From 5 Years High (%) -83.02
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
23 Sep 2020 19.840 20.100 18.900 18.910 1,035,463 -
22 Sep 2020 19.460 20.130 19.164 19.900 1,497,647 -
21 Sep 2020 19.740 19.790 18.940 19.410 1,142,216 -
18 Sep 2020 20.510 20.550 19.950 20.170 2,004,826 -
17 Sep 2020 20.070 20.480 19.860 20.340 969,475 -
16 Sep 2020 20.020 20.645 20.010 20.310 900,533 -
15 Sep 2020 19.910 20.410 19.820 20.010 1,184,066 -
14 Sep 2020 19.010 19.860 19.010 19.750 1,400,215 -
11 Sep 2020 19.000 19.230 18.590 18.820 687,249 -
10 Sep 2020 18.920 19.545 18.810 18.820 650,356 -
09 Sep 2020 18.650 19.090 18.470 18.850 811,426 -
08 Sep 2020 18.630 18.820 18.320 18.440 1,017,561 -
04 Sep 2020 19.230 19.410 18.160 18.920 1,512,219 -
03 Sep 2020 19.060 19.570 18.850 19.150 1,198,302 -
02 Sep 2020 19.200 19.410 19.060 19.200 714,905 -
01 Sep 2020 19.390 19.470 18.950 19.150 1,208,144 -
31 Aug 2020 19.130 19.460 19.090 19.340 635,706 -
28 Aug 2020 19.180 19.290 18.860 19.140 834,866 -
27 Aug 2020 19.400 19.570 19.020 19.170 1,120,445 -
26 Aug 2020 19.180 19.460 19.060 19.450 997,459 -
25 Aug 2020 19.220 19.690 18.940 19.335 839,639 -
24 Aug 2020 19.160 19.445 18.935 19.160 921,597 -
Summary
Current 2 Weeks
(10 Sep 2020 to 23 Sep 2020)
18.920 20.645 18.590 18.910 11,472,046 -
Previous 2 Weeks
(26 Aug 2020 to 09 Sep 2020)
19.180 20.645 18.590 18.850 10,051,033 -
4 Weeks from
(29 Jul 2020 to 25 Aug 2020)
23.160 23.200 18.590 19.335 16,764,198 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.